Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Ouabain

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44366   clinical trials with a EudraCT protocol, of which   7389   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    5 result(s) found for: Ouabain. Displaying page 1 of 1.
    EudraCT Number: 2020-001014-37 Sponsor Protocol Number: ALTUM Start Date*: 2020-08-13
    Sponsor Name:OSPEDALE SAN RAFFAELE
    Full Title: Pharmacogenetics of hypertension: randomized monocentric study in patients with essential hypertension and treated with Spironolactone or Torasemide
    Medical condition: Essential hypertension
    Disease: Version SOC Term Classification Code Term Level
    22.1 10047065 - Vascular disorders 10015489 Essential hypertension, benign LLT
    21.1 10047065 - Vascular disorders 10015488 Essential hypertension PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2014-002932-15 Sponsor Protocol Number: 2014-002932-15 Start Date*: 2014-09-10
    Sponsor Name:Bispebjerg University Hospital
    Full Title: The effect of inhaled glucocorticoids on the content of Na+/K+ pumps in human skeletal muscle
    Medical condition: Asthma
    Disease: Version SOC Term Classification Code Term Level
    17.0 10038738 - Respiratory, thoracic and mediastinal disorders 10003553 Asthma PT
    Population Age: Adults Gender: Male
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-000415-26 Sponsor Protocol Number: PST2238-DM-03-010 Start Date*: 2005-04-08
    Sponsor Name:Sigma-Tau
    Full Title: A double-blind, dose-range, placebo controlled study of the effects of PST2238 vs. placebo in patients with stable, uncomplicated, essential hypertension.
    Medical condition: Essential Hypertension
    Disease: Version SOC Term Classification Code Term Level
    7.0 10015488 LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IE (Completed) IT (Completed) CZ (Completed) ES (Completed) DE (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2016-003509-33 Sponsor Protocol Number: RECONSTRUCT Start Date*: 2016-11-30
    Sponsor Name:Lungemedicinsk Forskningsenhed, Bispebjerg Hospital
    Full Title: The RECONSTRUCT study Reconstructing Disease Mechanisms in Asthma
    Medical condition: Asthma
    Disease: Version SOC Term Classification Code Term Level
    19.0 10038738 - Respiratory, thoracic and mediastinal disorders 10003553 Asthma PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2011-000785-35 Sponsor Protocol Number: PAIR Start Date*: 2011-04-13
    Sponsor Name:IST. DI RICERCHE FARMACOLOG. M. NEGRI
    Full Title: A PROSPECTIVE STUDY TO ASSESS THE INTERACTION BETWEEN PATIENT GENOTYPE AND ROSTAFUROXIN EFFECTS ON ARTERIAL BLOOD PRESSURE AND KIDNEY FUNCTION IN NEVER-TREATED HYPERTENSIVE TYPE 2 DIABETES PATIENT...
    Medical condition: Type 2 Diabetes.
    Disease: Version SOC Term Classification Code Term Level
    14.1 10047065 - Vascular disorders 10015491 Essential hypertension, unspecified LLT
    14.1 10027433 - Metabolism and nutrition disorders 10012612 Diabetes mellitus non insulin-dep LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sat Dec 27 07:27:01 CET 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA